Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Visual outcome following optic neuritis: A 5-year review.
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
Literature Commentary.
Prediction of disability progression in fingolimod-treated patients.
[Clinical features and prognosis of pediatric multiple sclerosis].
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Switching and escalating therapy in long-lasting multiple sclerosis: not always necessary.
Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
Redox processes in neurodegenerative disease involving reactive oxygen species.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Hypercalcaemia and acute kidney injury following administration of vitamin D in granulomatous disease.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
Epstein-barr virus in the central nervous system and cervical lymph node of a patient with primary progressive multiple sclerosis.
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis.
Fatigue, depression, and physical impairment in multiple sclerosis.
The relationship of age, function, and psychological distress in multiple sclerosis.
Articulation time does not affect speeded cognitive performance in multiple sclerosis.
Recent imaging advances in neurology.
Time-Lapse Imaging of Glial-Axonal Interactions.
Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study.
Pages
« first
‹ previous
…
421
422
423
424
425
426
427
428
429
…
next ›
last »